Sort
23,748 grants matching “melanoma”
A PTEN-dependent cell size checkpoint in human cells
$241,207Todd A Waldman · Georgetown University · R01 · FY2015 · CA
A PTEN-dependent cell size checkpoint in human cells
$241,207Todd A Waldman · Georgetown University · R01 · FY2013 · CA
A PTEN-dependent cell size checkpoint in human cells
$241,207Todd A Waldman · Georgetown University · R01 · FY2016 · CA
Intravesical rF-GMCSF and rF-TRICOM in the treatment of advanced bladder cancer
$241,207Edmund C. Lattime · Univ Of Med/Dent Nj-R W Johnson Med Sch · R21 · FY2007 · CA
MOLECULAR STAGING OF HUMAN SQUAMOUS CELL SKIN CANCER
$241,107University Of New Mexico · R33 · FY2003 · CA
Predicting Metastasis in Melanoma
$241,099David L Rimm · Yale University · R01 · FY2013 · CA
Moffitt Cancer Center Support Grant
$241,075Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2015 · CA
Moffitt Cancer Center Support Grant
$241,075Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2016 · CA
Development of a novel cell-based immune therapy using Nanoparticles and natural IgM-producing phagocytic B cells
$241,061Xuemei Zhong · Boston Medical Center · R21 · FY2016 · CA
Targeting the ERK Pathway in KRAS-and BRAF-Driven Lung Cancers
$240,985Neal Rosen · Sloan-Kettering Inst Can Research · P01 · FY2014 · CA
CELL BASED TUMOR VACCINES TARGETING CD4+ T LUMPHOCYTES
$240,886University Of Maryland Balt Co Campus · R01 · FY2000 · CA
Development of ESiPSC approach for non-germline GEM modeling
$240,865Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
REGULATION OF UVEAL MELANOMA INTERCONVERTED PHENOTYPE
$240,829University Of Iowa · R01 · FY2000 · CA
Targeting Malignant Stem Cells in CLL
$240,810Margaret Goodell · Baylor College Of Medicine · P50 · FY2007 · CA
Identification of small molecule inhibitors of USP15
$240,788Anton Simeonov · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR
ORAL MELANOMA: ALPHA V BETA 3 EXPRESSION AND METASTASIS
$240,656University Of California San Francisco · R01 · FY2000 · DE
Core 2-MelCore biospecimens
$240,654Jeffrey E Gershenwald · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
Core 2-MelCore biospecimens
$240,653Jeffrey E Gershenwald · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA
H2 ALPHA GALACTOSYL EPITOPES AND TUMOR METASTASES
$240,603University Of Pittsburgh At Pittsburgh · R01 · FY2001 · CA
Understanding and Overcoming Resistance to Cancer Immunotherapy Due to Defective Antigen Presentation
$240,500Katerina Abigail Politi · Yale University · R01 · FY2019 · CA
Collaborative Research: Rational Design of Anticancer Drug Combinations using Dynamic Multidimensional Theory
$240,480Reka Z Albert · Pennsylvania State Univ University Park · · FY2016 · MPS
Collaborative Research: Rational Design of Anticancer Drug Combinations using Dynamic Multidimensional Theory
$240,480Raul Rabadan · Columbia University · · FY2016 · MPS
NOVEL APPROACAHES FOR IMPROVING PEDIATRIC BRAFV600E GLIOMA PATIENT OUTCOMES
$240,441Charles David James · University Of California, San Francisco · P50 · FY2014 · CA
Brain Metastasis Microenvironment and Mechanisms
$240,435Joan Massague · Fred Hutchinson Cancer Research Center · U54 · FY2013 · CA
EVALUATION OF CYCLOPHOSPHAMIDE WITH PEPTIDE VACCINES IN PARTICIPANTS W/MELANOMA
$240,429Craig Lee Slingluff · University Of Virginia · M01 · FY2008 · RR